✦ LIBER ✦

A prospective randomly controlled clinical trial on azithromycin therapy for induction treatment of children with nephrotic syndrome

✍ Scribed by Zhang, Bili; Liu, Tao; Wang, Wenhong; Zhang, Xuan; Fan, Shuying; Liu, Zhufeng; Liu, Zhe; Wu, Xia

Book ID: 125347517
Publisher: Springer
Year: 2013
Tongue: English
Weight: 244 KB
Volume: 173
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00431-013-2192-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tacrolimus is an alternative therapy opt

Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial

✍ Fan, Li; Liu, Qinghua; Liao, Yunhua; Li, Zhibin; Ji, Yulian; Yang, Zhenhua; Chen 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 273 KB

Treatment of giant cell arteritis using

Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial

✍ Mehrdad Mazlumzadeh; Gene G. Hunder; Kirk A. Easley; Kenneth T. Calamia; Eric L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract ## Objective Glucocorticoid (GC) therapy for giant cell arteritis (GCA) is effective but requires prolonged administration, resulting in adverse side effects. The goal of the current study was to test the hypothesis that induction treatment with high‐dose pulse intravenous (IV) methylp

Comparison of conservative treatment wit

Comparison of conservative treatment with and without manual physical therapy for patients with shoulder impingement syndrome: a prospective, randomized clinical trial

✍ Gamze Senbursa; Gul Baltacı; Ahmet Atay 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 292 KB

The effects of weight status on treatmen

The effects of weight status on treatment outcomes in a randomized clinical trial of multisystemic therapy for adolescents with type 1 diabetes and chronically poor metabolic control

✍ Nedim Cakan; Deborah A Ellis; Thomas Templin; Maureen Frey; Sylvie Naar-King 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB